A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

NCT03723655 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy

Interventions

DRUG: mavacamten

Sponsor

Bristol-Myers Squibb